Michael Curtis Crowe
CIK: 0002026683
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
COCH
Envoy Medical, Inc.
Director
Discretionary Trading P&L
Holdings
About Crowe Michael Curtis
Crowe Michael Curtis (SEC CIK 0002026683) files insider reports with the SEC as Director of Envoy Medical, Inc. (COCH).
Signal8 holds 1 ownership filing by Crowe Michael Curtis, a Form 4, filed on Dec 5, 2025. Those filings report 1 transaction, the latest on Dec 3, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Crowe Michael Curtis's filings is in WHITE BEAR LAKE, MN.
Recent filings by Crowe Michael Curtis
- Dec 3, 2025: Grant or award of COCH derivative securities (Form 4, code A).
Other insiders filing for Envoy Medical, Inc. (COCH)
- Potashnick Robert, CAO & VP of Finance
- Lucas Brent T., Chief Executive Officer
- McKhann Chas, Director
- Patel Mona Chetan, Director
- Kantor Susan, Director
- BRYNELSEN CHARLES, Director